J-shaped association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio

Ping Lv1, Chenze Zhao1, Yu Shan2

  • 1Heart Center, Department of Cardiovascular Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.

Insights

The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) shows a J-shaped link with heart failure (HF) risk. Both very low and very high NHHR levels are associated with increased HF risk in US adults.

Area of Science:

  • Cardiology
  • Lipid Metabolism
  • Public Health

Background:

  • The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) is a key lipid indicator for cardiovascular and metabolic diseases.
  • The association between NHHR and heart failure (HF) risk remains incompletely understood.

Purpose of the Study:

  • To investigate the relationship between NHHR and the prevalence of HF in a representative US adult population.
  • To explore the nature of this association, including potential non-linear effects and threshold points.

Main Methods:

  • Analysis of data from 11,639 adults in the National Health and Nutrition Examination Survey (2011-2018).
  • Multivariate logistic regression, restricted cubic splines (RCS), and piecewise logistic regression were used to assess NHHR-HF associations.
  • Subgroup and sensitivity analyses were performed to confirm the robustness of the findings.

Main Results:

  • A J-shaped relationship was identified between NHHR and HF risk, with an inflection point at NHHR = 2.58.
  • Both low (NHHR < 2.0) and high (NHHR ≥ 5.0) NHHR levels were significantly associated with increased HF risk compared to NHHR 2.0–3.0.
  • The association remained significant on both sides of the inflection point (OR < 2.58 = 0.545; OR ≥ 2.58 = 1.132).

Conclusions:

  • Both extremely low and high NHHR levels are independently associated with a higher risk of heart failure in US adults.
  • The relationship between NHHR and HF risk is non-linear, exhibiting a J-shaped curve with a critical inflection point at 2.58.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
704
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
313
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
558
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
207
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
465